Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
13.2M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
113K
-
Shares change
-
-47.8K
-
Total reported value, excl. options
-
$219K
-
Value change
-
-$86.7K
-
Number of buys
-
1
-
Number of sells
-
-4
-
Price
-
$1.95
Significant Holders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) as of Q1 2024
11 filings reported holding SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share as of Q1 2024.
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 113K shares
of 13.2M outstanding shares and own 0.85% of the company stock.
Largest 10 shareholders include Financial Advocates Investment Management (62.8K shares), VANGUARD GROUP INC (16.3K shares), GEODE CAPITAL MANAGEMENT, LLC (16.2K shares), STATE STREET CORP (12.5K shares), Tower Research Capital LLC (TRC) (4.43K shares), UBS Group AG (374 shares), Westside Investment Management, Inc. (94 shares), FWL INVESTMENT MANAGEMENT, LLC (80 shares), WELLS FARGO & COMPANY/MN (17 shares), and JPMORGAN CHASE & CO (1 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.